Echinacea purpurea up-regulates CYP1A2, CYP3A4 and MDR1 gene expression by activation of pregnane X receptor pathway

被引:29
作者
Awortwe, Charles [1 ]
Manda, Vamshi K. [2 ]
Avonto, Cristina [2 ]
Khan, Shabana I. [2 ,3 ]
Khan, Ikhlas A. [2 ,3 ]
Walker, Larry A. [2 ,4 ]
Bouic, Patrick J. [5 ,6 ]
Rosenkranz, Bernd [1 ]
机构
[1] Univ Stellenbosch, Fac Med & Hlth Sci, Div Clin Pharmacol, Cape Town, South Africa
[2] Univ Mississippi, Natl Ctr Nat Prod Res, Sch Pharm, Oxford, MS USA
[3] Univ Mississippi, Sch Pharm, Dept Biomol Sci, Div Pharmacognosy, Oxford, MS USA
[4] Univ Mississippi, Sch Pharm, Dept Biomol Sci, Div Pharmacol, Oxford, MS USA
[5] Synexa Life Sci, Montague Gardens, Cape Town, South Africa
[6] Univ Stellenbosch, Fac Med & Hlth Sci, Div Med Microbiol, Cape Town, South Africa
基金
美国农业部;
关键词
Activation; cytochrome P450 enzymes (CYPs); E; purpurea; human liver carcinoma (HepG2); human pregnane xenobiotic receptor (hPXR); DRUG-METABOLIZING-ENZYMES; ST-JOHNS-WORT; IN-VITRO; PHARMACEUTICAL RESEARCH; CYTOCHROME-P450; INDUCTION; MANUFACTURERS;
D O I
10.3109/00498254.2014.973930
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. This study investigated the mechanism underlying Echinacea-mediated induction of CYP1A2, CYP3A4 and MDR1 in terms of human pregnane X receptor (PXR) activation. 2. Crude extracts and fractions of Echinacea purpurea were tested for PXR activation in HepG2 cells by a reporter gene assay. Quantitative real-time PCR was carried out to determine their effects on CYP1A2 and CYP3A4 mRNA expressions. Capsules and fractions were risk ranked as high, intermediate and remote risk of drug-metabolizing enzymes induction based on EC50 values determined for respective CYPs. 3. Fractions F-1, F-2 and capsule ( 2660) strongly activated PXR with 5-, 4- and 3.5-fold increase in activity, respectively. Echinacea preparations potentiated up-regulation of CYP1A2, CYP3A4 and MDR1 via PXR activation. 4. Thus E. purpurea preparations cause herb-drug interaction by up-regulating CYP1A2, CYP3A4 and P-gp via PXR activation.
引用
收藏
页码:218 / 229
页数:12
相关论文
共 39 条
[1]   Distribution of cyclosporin in organ transplant recipients [J].
Akhlaghi, F ;
Trull, AK .
CLINICAL PHARMACOKINETICS, 2002, 41 (09) :615-637
[2]  
Awortwe Charles, 2014, Drug Metab Lett, V7, P83
[3]   ECHINACEA .5. TLC AND HPLC ANALYSIS OF ALKAMIDES IN ECHINACEA DRUGS [J].
BAUER, R ;
REMIGER, P .
PLANTA MEDICA, 1989, (04) :367-371
[4]  
Behm Dillon DM, 2004, ADV PHARMACOL, V2, P41
[5]   The conduct of in vitro and in vivo drug-drug interaction studies: A Pharmaceutical Research and Manufacturers of America (PhRMA) perspective [J].
Bjornsson, TD ;
Callaghan, JT ;
Einolf, HJ ;
Fischer, V ;
Gan, L ;
Grimm, S ;
Kao, J ;
King, SP ;
Miwa, G ;
Ni, L ;
Kumar, G ;
McLeod, J ;
Obach, RS ;
Roberts, S ;
Roe, A ;
Shah, A ;
Snikeris, F ;
Sullivan, JT ;
Tweedie, D ;
Vega, JM ;
Walsh, J ;
Wrighton, SA .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (07) :815-832
[6]   In Vitro and in Vivo Induction of Cytochrome P450: A Survey of the Current Practices and Recommendations: A Pharmaceutical Research and Manufacturers of America Perspective [J].
Chu, Valeria ;
Einolf, Heidi J. ;
Evers, Raymond ;
Kumar, Gondi ;
Moore, David ;
Ripp, Sharon ;
Silva, Jose ;
Sinha, Vikram ;
Sinz, Michael ;
Skerjanec, Andrej .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (07) :1339-1354
[7]   Clinically relevant safety issues associated with St. John's wort product labels [J].
Clauson, Kevin A. ;
Santamarina, Marile L. ;
Rutledge, Jennifer C. .
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2008, 8 (1)
[8]   Presence of synthetic pharmaceuticals as adulterants in slimming phytotherapeutic formulations and their analytical determination [J].
de Carvalho, Leandro M. ;
Martini, Mariele ;
Moreira, Ana Paula L. ;
de Lima, Ana Paula S. ;
Correia, Daniele ;
Falcao, Tatiana ;
Garcia, Solange C. ;
de Bairros, Andre V. ;
do Nascimento, Paulo C. ;
Bohrer, Denise .
FORENSIC SCIENCE INTERNATIONAL, 2011, 204 (1-3) :6-12
[9]   Induction of drug metabolism by forskolin: The role of the pregnane X receptor and the protein kinase A signal transduction pathway [J].
Ding, XS ;
Staudinger, JL .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (02) :849-856
[10]   Induction of drug metabolising enzymes - Pharmacokinetic and toxicological consequences in humans [J].
Fuhr, U .
CLINICAL PHARMACOKINETICS, 2000, 38 (06) :493-504